13F-HR filed by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 64 holding rows worth $6,401,901,127.
- Accession
- 0001493152-24-006286
- Filer
- CIK 1493215
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 64 entries on the cover page, a total value of $6,401,901,127 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,401,901,127 with VALUE read as dollars as filed, 13F file number 028-16670. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 17,687,772 | $530,102,527 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 6,096,387 | $416,505,160 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 6,768,514 | $397,650,198 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 4,489,596 | $357,326,946 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 11,253,551 | $352,348,682 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 6,887,086 | $329,340,453 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 1,640,559 | $314,019,398 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 667,195 | $253,820,994 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 3,344,095 | $245,724,101 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,525,080 | $210,818,929 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 7,423,970 | $204,604,613 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 815,191 | $188,618,894 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 4,213,483 | $173,426,960 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 1,462,400 | $171,407,904 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 662,664 | $166,686,503 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 2,593,323 | $162,445,753 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 3,463,201 | $137,350,552 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 5,315,514 | $121,884,736 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 5,175,832 | $119,820,511 | dollars as filed | |
| VERICEL CORP | 92346J108 | COM | 3,212,794 | $114,407,594 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 5,197,019 | $112,619,402 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 3,901,523 | $108,228,248 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 6,947,918 | $98,104,602 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 1,549,951 | $86,735,258 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 3,592,759 | $83,890,923 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 2,373,625 | $65,274,688 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 2,494,138 | $64,573,233 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 3,152,341 | $63,834,905 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 5,578,931 | $62,316,659 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 6,689,789 | $60,542,590 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 2,142,591 | $59,863,993 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,865,108 | $57,799,697 | dollars as filed | |
| ORCHESTRA BIOMED HOLDINGS IN | 68572M106 | COMMON STOCK | 5,620,640 | $51,316,443 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 2,232,760 | $48,048,995 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 5,469,956 | $36,922,203 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 16,893,185 | $29,900,937 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 118,584 | $27,433,223 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 50,000 | $26,539,500 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 1,726,808 | $25,902,120 | dollars as filed | |
| RADNET INC | 750491102 | COM | 663,602 | $23,073,442 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 625,000 | $22,812,500 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 4,131,045 | $21,729,297 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,966,752 | $19,470,845 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 3,327,129 | $19,297,348 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,454,273 | $16,331,486 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 1,484,911 | $15,636,113 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 2,298,662 | $15,171,169 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 492,977 | $13,335,028 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 605,816 | $13,194,673 | dollars as filed | |
| NULL | 02008G102 | NULL | 3,457,707 | $12,931,824 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 65,060 | $12,397,834 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 398,850 | $10,441,893 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 4,134,631 | $7,814,453 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 978,310 | $7,298,193 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 4,335,255 | $6,502,883 | dollars as filed | |
| CUTERA INC | 232109108 | COM | 1,817,585 | $6,406,987 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T103 | COM | 9,178,282 | $6,310,069 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 3,256,102 | $5,437,690 | dollars as filed | |
| EXAGEN INC | 30068X103 | COM | 1,504,602 | $2,994,158 | dollars as filed | |
| APYX MEDICAL CORPORATION | 03837C106 | COM | 1,025,963 | $2,688,023 | dollars as filed | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 127,970 | $1,394,873 | dollars as filed | |
| SIGHT SCIENCES INC | 82657M105 | COMMON STOCK | 164,806 | $850,399 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 350,000 | $171,500 | dollars as filed | |
| SIENTRA INC | 82621J204 | COMMON | 81,016 | $49,420 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-24-006286 | this filing | 2024-02-14 | acceptance time not in the bulk data set |